Vascuzyme 240 (OMP)

• Maintains Normal Inflammatory Balance
• Provides Support for a Healthy Immune Response
• Supports Recovery from Exercise and Physical Stress
• Helps Support Blood Vessel and Cardiovascular Health

Vascuzyme, also promotes recovery from exercise and physical stress by supporting the breakdown of unwanted proteins, aiding the body’s natural repair processes. For a normal recovery process, Vascuzyme has applications for a broad range of health needs. Vascuzyme’s enzyme blend includes, protease, amylase, papain, trypsin, lipase, chymotrypsin, bromelain and peptidase enzymes, along with quercetin and rutin, two well-known flavonoids.

Suggested Use:

2 capsules one to three times per day on an empty stomach or as recommended by your health care professional.

Research

Studies have highlighted the efficacy of systemic enzyme therapy for a variety of uses, including maintaining normal inflammatory balance, nasal passage health, bronchial health, musculoskeletal health and exercise-related recovery. In vitro, animal and human data show that enzyme therapies are capable of cleaving immune complexes, which are known inflammatory mediators. In one study, among four different types of immune complexes prepared in vitro and incubated with different concentrations of an enzyme mixture (papain or pancreatin) approximately 90% of the antigen complexes were cleaved by low doses of enzymes. In addition, antibody complexes were gradually cleaved by concentrations from 5-80 mg. Proteolytic enzymes have also been shown to reduce levels of the immune marker, TGF-β (Transforming Growth Factorbeta), by converting the protease inhibitor alpha2M from the slow form into the fast form, which binds and inactivates TGF-β. In one study, oral proteolytic enzyme therapy reduced TGF-β levels, maintaining normal inflammatory balance. Study done in children who were given either a polyenzyme mixture or a monoenzyme agent, found that those receiving the polyenzyme mix maintained optimal balance of proinflammatory cytokines (IL-2, IL-6, and TNF-α). Additionally, the beneficial cytokine IL-4 demonstrated the potency of polyenzyme therapy to maintain normal inflammatory balance and promote tissue recovery.